Therapeutic mesenchymal stem cells in rheumatic diseases: rationale, clinical data and perspectives - Archive ouverte HAL Access content directly
Journal Articles Clinical Investigation Year : 2011

Therapeutic mesenchymal stem cells in rheumatic diseases: rationale, clinical data and perspectives

(1) , (2) , (2) , (2, 3) , (2)
1
2
3

Abstract

Mesenchymal stem or stromal cells (MSCs) are easily isolated from bone marrow or fat tissue and their potential of multilineage differentiation has initially led to the development of strategies for tissue engineering applications. More recently, they have gained much interest based on their trophic and immunomodulatory properties that have stimulated their evaluation in various clinical trials aiming at modulating the host immune response in graft-versus-host disease or autoimmune diseases. The clinical applications of MSCs for rheumatic diseases are limited and address primarily their potential to help tissue repair/regeneration. The aim of the present review is to focus on the mechanisms by which MSCs might exhibit a therapeutic potential in rheumatology and present the current data on the undergoing clinical trials. Special attention is given to miRNA expression in rheumatic pathologies and their possible modulation for future innovative strategies as biomarkers or therapeutic targets.
Fichier principal
Vignette du fichier
1103-ClinInvest-revised.pdf (207.44 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00644029 , version 1 (01-10-2012)

Identifiers

  • HAL Id : inserm-00644029 , version 1

Cite

David Guérit, Marie Maumus, Florence Apparailly, Christian Jorgensen, Danièle Noël. Therapeutic mesenchymal stem cells in rheumatic diseases: rationale, clinical data and perspectives. Clinical Investigation, 2011, 1 (9), pp.1269-1277. ⟨inserm-00644029⟩
109 View
231 Download

Share

Gmail Facebook Twitter LinkedIn More